Aldo-keto reductases overexpressed in our cancer dataset (AKR1C1, AKR1B10, and AKR1C3) are involved in the reduction of retinal to retinol (Table 2 and Supplementary Table S1). This evidence concerns the gene AKR1C1 and cancer.